PRESENTERS
Kelly Kaihara, PhD, Market Development Scientist
ABSTRACT
Single-cell sequencing methods have enabled multi-modal characterization of tumor heterogeneity to yield novel insights into tumor evolution, therapeutic response & resistance in hematological disorders. Join us for an overview of the latest publications using the Tapestri Platform, which has the novel capability to co-detect SNVs, CNVs, and immunophenotype from the same cell with a single, high-throughput workflow.
